Lung in vitro models are defined as cell models that represent a normal or diseased lung physiology.
In 2018, North America is projected to account for the largest share of the global lung in vitro models market. The development in the market in North America is driven by the flourishing research environment and abundant funding program such as increased funds for the National Institutes of Health (NIH) and increased R&D activities by biotechnology and pharmaceutical companies.

Market Analysis and Insights: Global and China In Vitro Lung Model Market
This report focuses on global and China In Vitro Lung Model market.
In 2020, the global In Vitro Lung Model market size was US$ 183.1 million and it is expected to reach US$ 477.6 million by the end of 2027, with a CAGR of 14.2% during 2021-2027. In China the In Vitro Lung Model market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global In Vitro Lung Model Scope and Market Size
In Vitro Lung Model market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global In Vitro Lung Model market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the In Vitro Lung Model market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
2D Models
3D Models

Segment by Application
Drug Discovery and Toxicology
Physiological Research
Stem Cell Research and Regenerative Medicine

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Atcc
Lonza
Epithelix
Mattek
Emulate
Tissuse
Mimetas
Insphero
Cn Bio Innovations